Results of a large-scale screening programme to detect antibacterial activity from freshwater algae

Cannell, Richard J. P.; Owsianka, Ania M.; Walker, John M.

doi:10.1080/00071618800650051

Cited by 39 publications

(22 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Microalgae, particularly cyanobacteria, have received much less attention, largely because of difficulties in collection, mass cultivation and harvesting. Recent developments in large-scale culturing of algae have resulted in greater attention on the search for pharmaceuticals from a diverse group of algae including cyanobacteria (Flores & Wolk, 1986;Cannell et al, 1988;Gustafson et al, 1989;Patterson et al, 1991).…”

Section: Discussionmentioning

confidence: 99%

Current knowledge on potential health benefits of Spirulina

Belay¹,

Ota²,

Miyakawa³

et al. 1993

J Appl Phycol

355

174

View full text Add to dashboard Cite

Spirulina is a microscopic filamentous alga that is rich in proteins, vitamins, essential amino acids, minerals and essential fatty acids like y-linolenic acid (GLA). It is produced commercially and sold as a food supplement in health food stores around the world. Up to very recently, the interest in Spirulina was mainly in its nutritive value. Currently, however, numerous people are looking into the possible therapeutic effects of Spirulina. Many pre-clinical studies and a few clinical studies suggest several therapeutic effects ranging from reduction of cholesterol and cancer to enhancing the immune system, increasing intestinal lactobacilli, reducing nephrotoxicity by heavy metals and drugs and radiation protection. This paper presents a critical review of some published and unpublished data on therapeutic effects of Spirulina.

show abstract

Section: Discussionmentioning

confidence: 99%

Current knowledge on potential health benefits of Spirulina

Belay¹,

Ota²,

Miyakawa³

et al. 1993

J Appl Phycol

355

174

View full text Add to dashboard Cite

show abstract

“…The marine macro-algal species are dominated mainly by members of the Rhodophyceae, Phaeophyceae and Acetone extracts Antibacterial Cannell et al (1988) some of the Chlorophyceae. Compounds exhibiting antifouling, antialgal, antibacterial and antifungal properties have been isolated from these algae (Kubanek et al 2003;Smyrniotopoulos et al 2003;de Nys and Steinberg 2002;Steinberg and de Nys 2002;Vairappan et al 2001;Borchardt et al 2001;Kjelleberg and Steinberg 2001a;Steinberg et al 1998;Jakubowski 1995 1996;Walters et al 1996;de Nys et al 1995;Schmitt et al 1995;Clayton and King 1990;Ragan and Glombitza 1986;McLachlan and Craige 1964;Langlois 1975).…”

Section: Biogenic Compounds From the Dinophyceae And Chlorophyceae (Mmentioning

confidence: 99%

Exploitation of marine algae: biogenic compounds for potential antifouling applications

Bhadury

Wright

2004

Planta

289

173

View full text Add to dashboard Cite

Marine algae are one of the largest producers of biomass in the marine environment. They produce a wide variety of chemically active metabolites in their surroundings, potentially as an aid to protect themselves against other settling organisms. These active metabolites, also known as biogenic compounds, produced by several species of marine macro- and micro-algae, have antibacterial, antialgal, antimacrofouling and antifungal properties, which are effective in the prevention of biofouling, and have other likely uses, e.g. in therapeutics. The isolated substances with potent antifouling activity belong to groups of fatty acids, lipopeptides, amides, alkaloids, terpenoids, lactones, pyrroles and steroids. These biogenic compounds have the potential to be produced commercially using metabolic engineering techniques. Therefore, isolation of biogenic compounds and determination of their structure could provide leads for future development of, for example, environmentally friendly antifouling paints. This paper mainly discusses the successes of such research, and the future applications in the context of understanding the systems biology of micro-algae and cyanobacteria.

show abstract

“…Such types of microbial communities can disperse the effect caused by the inversion or addition of certain extrinsic pathogenic organisms. In addition, microorganisms can be sources of a variety of bioactive natural products of basic research and commercial interest that have inhibitory effect on microbial growth (Reichelt and Borowitska, 1984;Cannell et al, 1988). In aquaculture practices bacterial infectious diseases result in losses worldwide and to prevent them antimicrobial compounds are used intensively.…”

Section: Introductionmentioning

confidence: 99%

Antagonistic activity of cellular components of Pseudomonas species against Aeromonas hydrophila

et al. 2006

View full text Add to dashboard Cite

Antagonistic effects of Pseudomonas fluorescens, P. aeruginosa and P. putida were studied against 12 strains of Aeromonas hydrophila (Ah1-Ah12). Four different fractions of cellular component (i.e. whole cell product, heat killed whole cell product, intra cellular product and extra cellular product) of all Pseudomonas species were equally effective in reducing growth of A. hydrophila strains, as measured by the zone of inhibition in an in vitro sensitivity test and have potential action against A. hydrophila infection in fishes. D

show abstract

Results of a large-scale screening programme to detect antibacterial activity from freshwater algae

Cited by 39 publications

References 8 publications

Current knowledge on potential health benefits of Spirulina

Current knowledge on potential health benefits of Spirulina

Exploitation of marine algae: biogenic compounds for potential antifouling applications

Antagonistic activity of cellular components of Pseudomonas species against Aeromonas hydrophila

Contact Info

Product

Resources

About